Literature DB >> 33709819

Defining abnormal cold sensitivity using the Cold Intolerance Symptom Severity questionnaire: a population study.

Albin Stjernbrandt1, Ingrid Liljelind1, Tohr Nilsson1, Jens Wahlström1.   

Abstract

Cold sensitivity, a common and disabling sequela of hand injury, can be assessed using the Cold Intolerance Symptom Severity (CISS) questionnaire, rating symptoms on a scale from 4 to 100. The primary objective of this study was to define a clinical cut-off for abnormal cold sensitivity based on the CISS score in a healthy working-age population. The secondary objective was to investigate how age, gender and previous injuries and diseases influence CISS scoring. In this study, 1239 out of 1582 selected healthy subjects of working age living in northern Sweden completed the questionnaire, yielding a response rate of 78%. The 95th percentile for the CISS score was 49.5 for men and 53.0 for women. The effects of age, gender and previous injuries and diseases were minor and not considered clinically relevant. The results support that a CISS score above 50 should be considered as abnormal cold sensitivity.Level of evidence: III.

Entities:  

Keywords:  Hand; Sweden; cold exposure; hand-arm vibration; nerve injury; occupational exposure

Year:  2021        PMID: 33709819     DOI: 10.1177/1753193421996221

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  2 in total

1.  Cold sensitivity and its association to functional disability following a major nerve trunk injury in the upper extremity-A national registry-based study.

Authors:  Drifa Frostadottir; Linnéa Ekman; Malin Zimmerman; Lars B Dahlin
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

2.  Cold sensitivity, functional disability and predicting factors after a repaired digital nerve injury.

Authors:  Drifa Frostadottir; Linnéa Ekman; Malin Zimmerman; Stina Andersson; Marianne Arner; Elisabeth Brogren; Lars B Dahlin
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.